Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma

Specific HPV DNA sequences are associated with more than 90% of invasive carcinomas of the uterine cervix. Viral E6 and E7 oncogenes are key mediators in cell transformation by disrupting TP53 and RB pathways. To investigate molecular mechanisms involved in the progression of invasive cervical carcinoma, we performed a gene expression study on cases selected according to viral and clinical parameters. Using Coupled Two-Way Clustering and Sorting Points Into Neighbourhoods methods, we identified a ‘cervical cancer proliferation cluster’ composed of 163 highly correlated transcripts. Most of these transcripts corresponded to E2F pathway genes controlling cell division or proliferation, whereas none was known as TP53 primary target. The average expression level of the genes of this cluster was higher in tumours with an early relapse than in tumours with a favourable course (P=0.026). Moreover, we found that E6/E7 mRNA expression level was positively correlated with the expression level of the cluster genes and with viral DNA load. These findings suggest that HPV E6/E7 expression level plays a key role in the progression of invasive carcinoma of the uterine cervix via the deregulation of cellular genes controlling tumour cell proliferation. HPV expression level may thus provide a biological marker useful for prognosis assessment and specific therapy of the disease.

[1]  Hanlin L. Wang,et al.  Detection of Human Papillomavirus DNA and Expression of p16, Rb, and p53 Proteins in Small Cell Carcinomas of the Uterine Cervix , 2004, The American journal of surgical pathology.

[2]  S. Koi,et al.  Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. , 1989, Virology.

[3]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[4]  Russ B. Altman,et al.  Missing value estimation methods for DNA microarrays , 2001, Bioinform..

[5]  Dan Tsafrir,et al.  Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matrices , 2005, Bioinform..

[6]  L. Tippett,et al.  Applied Statistics. A Journal of the Royal Statistical Society , 1952 .

[7]  D. Mutch,et al.  Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  V. Georgiev Virology , 1955, Nature.

[9]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[10]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[11]  M. Grace,et al.  Mechanisms of Human Papillomavirus-Induced Oncogenesis , 2004, Journal of Virology.

[12]  P. Howley,et al.  Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Vincent-Salomon,et al.  Human papillomavirus genotype as a major determinant of the course of cervical cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[15]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[16]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[17]  B. Aronow,et al.  Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[19]  G. Getz,et al.  Coupled two-way clustering analysis of gene microarray data. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Vincent-Salomon,et al.  Overexpression/Amplification of HER-2/neu is Uncommon in Invasive Carcinoma of the Uterine Cervix , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[21]  S. Schneider-Maunoury,et al.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression , 1991, Journal of virology.

[22]  P. Lambert,et al.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.

[23]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[24]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[25]  X. Sastre-Garau,et al.  Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. , 2000, The Journal of general virology.

[26]  B. Monk,et al.  Human Papillomavirus Type 18: Association With Poor Prognosis in Early Stage Cervical Cancer , 1996 .

[27]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .